Association between right ventricular dysfunction and mortality in COVID-19 patients: A systematic review and meta-analysis

Carlos Diaz-Arocutipa, Jose Saucedo-Chinchay, Edgar Argulian

Research output: Contribution to journalReview articlepeer-review

12 Scopus citations


There is limited evidence about the prognostic utility of right ventricular dysfunction (RVD) in patients with coronavirus disease 2019 (COVID-19). We assessed the association between RVD and mortality in COVID-19 patients. We searched electronic databases from inception to February 15, 2021. RVD was defined based on the following echocardiographic variables: tricuspid annular plane systolic excursion (TAPSE), tricuspid S′ peak systolic velocity, fractional area change (FAC), and right ventricular free wall longitudinal strain (RVFWLS). All meta-analyses were performed using a random-effects model. Nineteen cohort studies involving 2307 patients were included. The mean age ranged from 59 to 72 years and 65% of patients were male. TAPSE (mean difference [MD], −3.13 mm; 95% confidence interval [CI], −4.08–−2.19), tricuspid S′ peak systolic velocity (MD, −0.88 cm/s; 95% CI, −1.68 to −0.08), FAC (MD, −3.47%; 95% CI, −6.21 to −0.72), and RVFWLS (MD, −5.83%; 95% CI, −7.47–−4.20) were significantly lower in nonsurvivors compared to survivors. Each 1 mm decrease in TAPSE (adjusted hazard ratio [aHR], 1.22; 95% CI, 1.08–1.37), 1% decrease in FAC (aHR, 1.09; 95% CI, 1.04–1.14), and 1% increase in RVFWLS (aHR, 1.33; 95% CI, 1.19–1.48) were independently associated with higher mortality. RVD was significantly associated with higher mortality using unadjusted risk ratio (2.05; 95% CI, 1.27–3.31), unadjusted hazard ratio (3.37; 95% CI, 1.72–6.62), and adjusted hazard ratio (aHR, 2.75; 95% CI, 1.52–4.96). Our study shows that echocardiographic parameters of RVD were associated with an increased risk of mortality in COVID-19 patients.

Original languageEnglish
Pages (from-to)1360-1370
Number of pages11
JournalClinical Cardiology
Issue number10
StatePublished - Oct 2021


  • Aged
  • COVID-19
  • Humans
  • Male
  • Middle Aged
  • SARS-CoV-2
  • Systole
  • Ventricular Dysfunction, Right/diagnostic imaging
  • Ventricular Function, Right


Dive into the research topics of 'Association between right ventricular dysfunction and mortality in COVID-19 patients: A systematic review and meta-analysis'. Together they form a unique fingerprint.

Cite this